Assay of β-glucosidase 2 (GBA2) activity using lithocholic acid β-3-O-glucoside substrate for cultured fibroblasts and glucosylceramide for brain tissue
Keyword(s):
Abstract Beta (β)-glucosidase 2 (GBA2) is deficient in a form of human spastic paraplegia due to defects in GBA2 (SPG46). GBA2 was proposed as a modifier of Gaucher disease, a lysosomal storage disease resulting from deficient β-glucosidase 1; GBA1. Current GBA2 activity assays using artificial substrates incompletely model the activity encountered in vivo. We studied GBA2 activity, using lithocholic acid β-glucoside or glucosylceramide as natural β-glucosidase substrates in murine tissues or cultured patient fibroblasts with the pathologic genotypes: Gba1−/−; Gba2−/−; GBA1−/−; GBA2+/− and found expected and unexpected deviations from normal controls.
2000 ◽
Vol 47
(6)
◽
pp. 757-762
◽
Keyword(s):
1981 ◽
Vol 76
(2)
◽
pp. 119-125
◽
Keyword(s):
Keyword(s):